Study on type Ⅱ collagen-specific cellular and humoral immune reactions in C57BL/6 mice with collagen-induced arthritis
Xiao-yan LI,Ping ZHU,Chun-mei FAN,Yan-hong WANG,Jun-feng JIA,Zhao-hui ZHENG
DOI: https://doi.org/10.3760/j:issn:1007-7480.2005.04.006
2005-01-01
Abstract:Objective To compare the primary (19 days) and secondary (7 days, and 28 days) CⅡ-specific cellular and antibody responses in C57BL/6 mice. Methods C57BL/6 mice were immunized with emulsified chicken type Ⅱ collagen (CⅡ) in complete Freund′s adjuvant by intradermal injection to induce the collagen-induced arthritis (CIA) mice model. The lymphocytes were obtained from spleen of CIA mice killed at 19 days after initial immunization and 7 days, 28 days after booster immunization, and the CⅡ reactive T cells were stimulated by CⅡ in vitro. The proliferation response and phenotype were analyzed by BrdU incorporation and fluorescence-activated cell sorter (FACS); intracellular cytokines (IFN-γ, IL-4) and surface antigen(CD4) of T cells in the peripheral blood of CIA mice were assayed by FACS; anti-CⅡ antibody in serum was assayed by enzyme-linked immunoadsorbent assay (ELISA) at different timepoints after immunization (7, 14, 21, 28, 35, 42, and 49 days). Results ① The representation of the Th1 cytokine IFN-γ in the peripheral blood of CIA mice was significantly higher than control groups (P0.01); but a similar representation was observed in the peripheral blood of CIA mice at different timepoints after immun-ization; ② In vitro, the frequency of BrdU+ cells in CD4+ T cells stimulated by CⅡ was significantly higher than that of control group (P0.01). But CD4+ T cells at 7 days, and 28 days after booster immunization had significantly lower proliferative responses against CⅡ than those of at the initial immunization [the frequency of BrdU+ cells was(72±6)%; and the percentage of IFN-γ-positive cells was (13±4)%]; subsequently there was gradually decreased proliferative responses against CⅡ following secondary boosting immunization; ③ At 28 days of initial immunization, the level of anti-CⅡ antibody in serum reached its peak, and then gradually decreased; at 35 days of initial immunization there was significantly lower level of anti-CⅡ antibody. Conclusion A low specific T cell and B cell responses after secondary immunization in B6 mice leads to the resistance to CIA, and provides a new research clue for CIA and RA pathogenesis and therapy.